Early research (Phase 1)Study completedNCT00575393What this trial is testingGold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer Mayo Clinic 17
Not applicableStudy completedNCT00900328What this trial is testingStudy of Tumor Samples From Patients With Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 280
Testing effectiveness (Phase 2)Ended earlyNCT00519831What this trial is testingPh II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCWho this might be right forLung Cancer UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT00351039What this trial is testingPhase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer H. Lee Moffitt Cancer Center and Research Institute 8
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT01179269What this trial is testingPazopanib and Paclitaxel for Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Loyola University
Early research (Phase 1)Study completedNCT00533585What this trial is testingBAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00006229What this trial is testingPaclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer NCIC Clinical Trials Group 774
Early research (Phase 1)Active Not RecruitingNCT05334329What this trial is testingGenetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint InhibitorsWho this might be right forAdvanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell Carcinoma+8 more University of California, Irvine 6
Not applicableStudy completedNCT02458651What this trial is testingDisease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in ChinaWho this might be right forNon-Small Cell Lung Cancer, Lung Cancer, Cancer Hoffmann-La Roche 1,378
Large-scale testing (Phase 3)Ended earlyNCT00858364What this trial is testingAnemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyWho this might be right forNon-Small Cell Lung CancerAnemiaCancer+1 more Amgen 2,549
Testing effectiveness (Phase 2)Study completedNCT00661193What this trial is testingS0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer SWOG Cancer Research Network 59
Testing effectiveness (Phase 2)Ended earlyNCT00754923What this trial is testingSorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Ohio State University Comprehensive Cancer Center 11
Early research (Phase 1)Looking for participantsNCT03819296What this trial is testingRole of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerWho this might be right forClinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more M.D. Anderson Cancer Center 800
Large-scale testing (Phase 3)Active Not RecruitingNCT03793179What this trial is testingTesting the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerWho this might be right forLung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8+1 more National Cancer Institute (NCI) 600
Not applicableStudy completedNCT00003329What this trial is testingIdentification of Genes Associated With Cancer in Patients and Siblings Who Have CancerWho this might be right forBreast CancerColorectal CancerLung Cancer+1 more Eastern Cooperative Oncology Group 4,000
Testing effectiveness (Phase 2)Study completedNCT00069875What this trial is testingA Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Eli Lilly and Company 195
Testing effectiveness (Phase 2)Study completedNCT00126581What this trial is testingErlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerWho this might be right forLung AdenocarcinomaLung Adenosquamous CarcinomaMalignant Pericardial Effusion+4 more National Cancer Institute (NCI) 188
Not applicableStudy completedNCT00303914What this trial is testingStudy of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+4 more Eastern Cooperative Oncology Group 2,310
Early research (Phase 1)Study completedNCT00052338What this trial is testingBortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerWho this might be right forMalignant Pleural EffusionRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+1 more National Cancer Institute (NCI) 34